| # | Drug | Count |
|---|---|---|
| 0 | LENALIDOMIDE | 428 |
| 1 | DEXAMETHASONE | 395 |
| 2 | DEXAMETHASONE 1.5 MG | 390 |
| 3 | CYCLOPHOSPHAMIDE | 351 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 351 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 351 |
| 6 | METHOTREXATE SODIUM | 328 |
| 7 | METHOTREXATE | 290 |
| 8 | BLINATUMOMAB | 251 |
| 9 | CYTARABINE | 206 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BLINATUMOMAB | 251 | 0.0234 |
| 1 | INOTUZUMAB OZOGAMICIN | 47 | 0.0157 |
| 2 | PONATINIB HYDROCHLORIDE | 73 | 0.0139 |
| 3 | CLOFARABINE | 27 | 0.0118 |
| 4 | DASATINIB | 93 | 0.0100 |
| 5 | NELARABINE | 8 | 0.0082 |
| 6 | CASPOFUNGIN ACETATE | 13 | 0.0082 |
| 7 | DEFIBROTIDE SODIUM | 29 | 0.0081 |
| 8 | AMIKACIN SULFATE | 10 | 0.0057 |
| 9 | DAUNORUBICIN HYDROCHLORIDE | 9 | 0.0055 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 623 |
| 1 | Thalidomide Analog [EPC] | 437 |
| 2 | Alkylating Drug [EPC] | 428 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 289 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 286 |
| 5 | Proteasome Inhibitor [EPC] | 175 |
| 6 | Azole Antifungal [EPC] | 171 |
| 7 | Topoisomerase Inhibitor [EPC] | 145 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 133 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 111 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 47 | 0.0157 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 38 | 0.0065 |
| 2 | Interleukin-6 Antagonist [EPC] | 4 | 0.0062 |
| 3 | Actinomycin [EPC] | 9 | 0.0041 |
| 4 | Vasoconstrictor [EPC] | 1 | 0.0033 |
| 5 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 6 | Hematopoietic Stem Cell Mobilizer [EPC] | 3 | 0.0020 |
| 7 | Echinocandin Antifungal [EPC] | 16 | 0.0019 |
| 8 | Topoisomerase Inhibitor [EPC] | 145 | 0.0019 |
| 9 | Alkylating Drug [EPC] | 428 | 0.0018 |